Alhambra Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $408K | Buy |
16,813
+3,785
| +29% | +$91.7K | 0.2% | 109 |
|
|
2025
Q1 | $330K | Sell |
13,028
-233
| -2% | -$5.9K | 0.17% | 121 |
|
|
2024
Q4 | $352K | Buy |
13,261
+26
| +0.2% | +$690 | 0.18% | 119 |
|
|
2024
Q3 | $383K | Buy |
13,235
+1,970
| +17% | +$57K | 0.2% | 119 |
|
|
2024
Q2 | $315K | Buy |
11,265
+2,265
| +25% | +$63.4K | 0.17% | 123 |
|
|
2024
Q1 | $250K | Sell |
9,000
-1,337
| -13% | -$37.1K | 0.14% | 138 |
|
|
2023
Q4 | $298K | Sell |
10,337
-3,288
| -24% | -$94.7K | 0.18% | 124 |
|
|
2023
Q3 | $452K | Sell |
13,625
-295
| -2% | -$9.79K | 0.3% | 94 |
|
|
2023
Q2 | $511K | Sell |
13,920
-9,224
| -40% | -$338K | 0.34% | 82 |
|
|
2023
Q1 | $944K | Buy |
23,144
+1,412
| +6% | +$57.6K | 0.65% | 43 |
|
|
2022
Q4 | $1.11M | Sell |
21,732
-126
| -0.6% | -$6.46K | 0.81% | 34 |
|
|
2022
Q3 | $956K | Buy |
21,858
+533
| +2% | +$23.3K | 0.73% | 35 |
|
|
2022
Q2 | $1.12M | Buy |
21,325
+946
| +5% | +$49.6K | 0.81% | 30 |
|
|
2022
Q1 | $1.06M | Buy |
20,379
+9,152
| +82% | +$474K | 0.7% | 35 |
|
|
2021
Q4 | $663K | Hold |
11,227
| – | – | 0.46% | 70 |
|
|
2021
Q3 | $483K | Buy |
11,227
+100
| +0.9% | +$4.3K | 0.37% | 89 |
|
|
2021
Q2 | $436K | Buy |
11,127
+185
| +2% | +$7.25K | 0.33% | 94 |
|
|
2021
Q1 | $396K | Sell |
10,942
-360
| -3% | -$13K | 0.32% | 98 |
|
|
2020
Q4 | $416K | Sell |
11,302
-576
| -5% | -$21.2K | 0.44% | 79 |
|
|
2020
Q3 | $414K | Buy |
11,878
+223
| +2% | +$7.77K | 0.5% | 67 |
|
|
2020
Q2 | $362K | Sell |
11,655
-391
| -3% | -$12.1K | 0.48% | 62 |
|
|
2020
Q1 | $373K | Sell |
12,046
-1,672
| -12% | -$51.8K | 0.61% | 43 |
|
|
2019
Q4 | $510K | Buy |
+13,718
| New | +$510K | 0.59% | 45 |
|